| Literature DB >> 30948423 |
Xiao Fen Hu1, Bo Zhang1, Chun Hua Liao1, Zhi Jiang Zeng2.
Abstract
The honeybee (Apis mellifera) is an important insect pollinator of wild flowers and crops, playing critical roles in the global ecosystem. Additionally, the honeybee serves as an ideal social insect model. Therefore, functional studies on honeybee genes are of great interest. However, until now, effective gene manipulation methods have not been available in honeybees. Here, we reported an improved CRISPR/Cas9 gene-editing method by microinjecting sgRNA and Cas9 protein into the region of zygote formation within 2 hr after queen oviposition, which allows one-step generation of biallelic knockout mutants in honeybee with high efficiency. We first targeted the Mrjp1 gene. Two batches of honeybee embryos were collected and injected with Mrjp1 sgRNA and Cas9 protein at the ventral cephalic side and the dorsal posterior side of the embryos, respectively. The gene-editing rate at the ventral cephalic side was 93.3%, which was much higher than that (11.8%) of the dorsal-posterior-side injection. To validate the high efficiency of our honeybee gene-editing system, we targeted another gene, Pax6, and injected Pax6 sgRNA and Cas9 protein at the ventral cephalic side in the third batch. A 100% editing rate was obtained. Sanger sequencing of the TA clones showed that 73.3% (for Mrjp1) and 76.9% (for Pax6) of the edited current-generation embryos were biallelic knockout mutants. These results suggest that the CRISPR/Cas9 method we established permits one-step biallelic knockout of target genes in honeybee embryos, thereby demonstrating an efficient application to functional studies of honeybee genes. It also provides a useful reference to gene editing in other insects with elongated eggs.Entities:
Keywords: CRISPR/Cas9; biallelic knockout; gene editing; honeybee
Mesh:
Substances:
Year: 2019 PMID: 30948423 PMCID: PMC6505149 DOI: 10.1534/g3.119.400130
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Figure 1Embryo slices for the 0-2, 4-6 and 6-8 h samples. The white arrow denotes the energid. Scale bar = 100 μm.
Differences in gene editing efficiency of Mrjp1 or Pax6 at the different injection sites
| Batch | Target gene | Injection site | Total | Survival1 (%) | Mutated (%) | Biallelic knockout | |
|---|---|---|---|---|---|---|---|
| Non-mosaic (%) | Mosaic (%) | ||||||
| Dorsal posterior side | 26 | 17 (65.4%) | 2 (11.8%) | 0 | 0 | ||
| Ventral cephalic side | 24 | 15 (62.5%) | 14 (93.3%) | 5 (33.3%) | 6 (40.0%) | ||
| Ventral cephalic side | 22 | 13 (59.1%) | 13 (100.0%) | 3 (23.1%) | 7 (53.8%) | ||
, the number of injected embryos that have developed into stage 9.
Figure 2Gene editing patterns of Mrjp1 gene. A deletion; B insertion. The two sequences shown at the top are wild-type sequences of WT-M1 and WT-M2. Letters in gray boxes and in blank boxes with a black frame indicate PAM and sgRNA target site, respectively. Star indicates SNP of T/C in wild-type sequence. White letters and dashes in the black boxes indicate inserted and deleted nucleotide sequences, respectively. Sequence type from which each sequence type was detected are shown on the left. The numbers of nucleotide deletions or insertion that differed between the genome-edited embryos and wild-type (WT) sequences are shown on the right.
The editing types of all edited individuals in three batches of experiments
| Injection site | ID | Target gene | Editing type (number) | Editing Rate |
|---|---|---|---|---|
| 1A | Wild-type(12) M15(8) | 8/20 = 40% | ||
| 2A | Wild-type (14) M12(1) M15(5) | 6/20 = 30% | ||
| 3A | M1(14) M2(1) M3(1) M6(3) M15(1) | 20/20 = 100% | ||
| 4A | M8 | 100% | ||
| 5A | M6 | 100% | ||
| 6A | Wild-type(8)M8(12) | 12/20 = 60% | ||
| 8A | M6 | 100% | ||
| 9A | M5(12) M8(8) | 20/20 = 100% | ||
| 10A | M4(14) M13(6) | 20/20 = 100% | ||
| 11A | M8 | 100% | ||
| 12A | M11(2) M15(18) | 20/20 = 100% | ||
| 13A | M6 | 100% | ||
| 14A | M8(14) M9(5) M14(1) | 20/20 = 100% | ||
| 15A | M8(10) M10(10) | 20/20 = 100% | ||
| 1D | Wild-type(1) P6(19) | 19/20 = 95% | ||
| 2D | P11 | 100% | ||
| 3D | Wild-type(1) P7(16) P14(3) | 19/20 = 95% | ||
| 4D | P9(2) P16(18) | 20/20 = 100% | ||
| 5D | P7(16) P15(4) | 20/20 = 100% | ||
| 6D | P1(3) P7(17) | 20/20 = 100% | ||
| 7D | P4(17) P5(1) P7(1) P10(1) | 20/20 = 100% | ||
| 8D | P7(1) P3(19) | 20/20 = 100% | ||
| 9D | P7 | 100% | ||
| 10D | P7(1) P8(1) P13(18) | 20/20 = 100% | ||
| 11D | P2(10) P7(1) P13(9) | 20/20 = 100% | ||
| 12D | P12(20) | 20/20 = 100% | ||
| 13D | Wild-type(1) P7(19) | 19/20 = 95% | ||
| 6C | Wild-type(19) M7(1) | 1/20 = 5% | ||
| 8C | Wild-type(14) M6(6) | 6/20 = 30% |
Note: 4A, 5A, 8A, 11A, 13A, 2D, 9D and 12D were biallelic homozygous mutants; 3A, 9A, 10A, 12A, 14A, 15A, 4D, 5D, 6D, 7D, 8D, 10D and 11D were biallelic heterozygous mutants.
Figure 3Gene editing patterns of Pax6 gene. A deletion; B insertion. The two sequences shown at the top are wild-type sequences of WT-P1 and WT-P2. Letters in gray boxes and in blank boxes with a black frame indicate PAM and sgRNA target site, respectively. Star indicates SNP of G/A in wild-type sequence. White letters and dashes in the black boxes indicate inserted and deleted nucleotide sequences, respectively. Sequence type from which each sequence type was detected are shown on the left. The numbers of nucleotide deletions or insertion that differed between the genome-edited embryos and wild-type (WT) sequences are shown on the right.